Acotiamide
- Generic Name
- Acotiamide
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30N4O5S
- CAS Number
- 185106-16-5
- Unique Ingredient Identifier
- D42OWK5383
- Background
Acotiamide has been used in trials studying the treatment of Dyspepsia and Functional Dyspepsia.
Helicobacter Pylori Eradication in Functional Dyspepsia
Not Applicable
Completed
- Conditions
- DyspepsiaHelicobacter Pylori Infection
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Sir Ganga Ram Hospital
- Target Recruit Count
- 202
- Registration Number
- NCT04697641
- Locations
- 🇮🇳
Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi, India
A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia
Phase 3
Recruiting
- Conditions
- Functional Dyspepsia
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Zeria Pharmaceutical
- Target Recruit Count
- 100
- Registration Number
- NCT04526119
- Locations
- 🇯🇵
Zeria Investigative Site, Matsumoto, Nagano, Japan
Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 20
- Registration Number
- NCT03402984
- Locations
- 🇧🇪
Jan Tack, Leuven, Belgium
Phase III, Long-term, Open-label Safety Study of Z-338
- First Posted Date
- 2013-11-01
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- Zeria Pharmaceutical
- Target Recruit Count
- 207
- Registration Number
- NCT01973790
- Locations
- 🇱🇻
Zeria Investivgative SIte, Limbazi, Latvia
🇱🇻Zeria Invetigative Site, Liepaja, Latvia
🇸🇪Zeria Investigative Sites, Stockholm, Sweden
Effect of Food Intake on Pharmacokinetic Profiles of Z-338
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2009-07-20
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 30
- Registration Number
- NCT00920998
A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults
Phase 1
Completed
- Conditions
- Functional Dyspepsia
- Interventions
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 80
- Registration Number
- NCT00850746
A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
- First Posted Date
- 2008-10-02
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 412
- Registration Number
- NCT00764374
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2010-11-23
- Lead Sponsor
- Zeria Pharmaceutical
- Target Recruit Count
- 820
- Registration Number
- NCT00761358
The Effect of Z-338 in Subjects With Functional Dyspepsia
Phase 2
Completed
- Conditions
- Functioanl Dyspepsia
- First Posted Date
- 2007-04-10
- Last Posted Date
- 2010-11-23
- Lead Sponsor
- Zeria Pharmaceutical
- Target Recruit Count
- 40
- Registration Number
- NCT00458328
- Locations
- 🇯🇵
Kawasaki Medical School, Kurashiki, Okayama, Japan
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia
Phase 2
Completed
- Conditions
- Functional Dyspepsia
- First Posted Date
- 2006-06-05
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- Zeria Pharmaceutical
- Target Recruit Count
- 440
- Registration Number
- NCT00333372
- Locations
- 🇯🇵
Tohoku University, Sendai, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath